| Table IV.2: The Number of States That Reported Conducting Different Types of Inspections for Resident (In-State) and Nonresident (Out-of-State) Pharmacies, and Other Entities | ||||
|---|---|---|---|---|
| Type of inspection (number of states) | ||||
| Type of licensed or registered entity | Pre-licensure | One time only (post-licensure) | For cause (e.g., in response to complaint) | Recurring |
| Resident pharmacy | 39 | 2 | 44 | 43 |
| Nonresident pharmacy | 1 | 0 | 1 | 2 |
| Resident sterile compounding pharmacya | 28 | 0 | 33 | 38 |
| Nonresident sterile compounding pharmacya | 3 | 0 | 2 | 4 |
| Resident wholesale distributor | 33 | 4 | 34 | 29 |
| Nonresident wholesale distributor | 1 | 0 | 1 | 1 |
| Resident outsourcing facility | 21 | 1 | 22 | 23 |
| Nonresident outsourcing facility | 3 | 0 | 1 | 3 |
| Source: GAO survey of state pharmacy regulatory bodies, survey question 17. | GAO-17-363SP |
| Notes: GAO surveyed the state pharmacy regulatory bodies in the 50 states, the District of Columbia, Guam, Puerto Rico, and the U.S. Virgin Islands, and all but 4 completed the survey. |
| aTwelve states reported having a separate state license category for resident sterile compounding pharmacies, and 12 states reported having a category for nonresident sterile compounding pharmacies; however, some states reported that they inspect pharmacies they know are compounding sterile drugs even if their state does not have a specific license category for these entities. |